Baader Bank Aktiengesellschaft’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,077
Closed -$517K 487
2025
Q3
$517K Buy
7,077
+824
+13% +$56.5K 0.03% 268
2025
Q2
$430K Buy
6,253
+2,411
+63% +$158K 0.03% 276
2025
Q1
$250K Buy
+3,842
New +$230K 0.02% 315
2024
Q4
Sell
-5,841
Closed -$319K 409
2024
Q3
$319K Buy
+5,841
New +$341K 0.02% 288
2023
Q1
Sell
-5,960
Closed -$555K 403
2022
Q4
$555K Buy
5,960
+1,950
+49% +$188K 0.03% 261
2022
Q3
$382K Buy
4,010
+1,250
+45% +$124K 0.02% 280
2022
Q2
$256K Sell
2,760
-106,881
-97% -$10.4M 0.02% 296
2022
Q1
$11.1M Buy
109,641
+500
+0.5% +$52.5K 0.89% 27
2021
Q4
$11.3M Buy
+109,141
New +$10.1M 0.87% 26

Other funds holding CVS

Baader Bank Aktiengesellschaft's CVS Position: Q4 2025 in Review

Baader Bank Aktiengesellschaft sold out of CVS Health (CVS) in Q4 2025, closing a stake of 7,077 shares — an estimated $517K sold.

Baader Bank Aktiengesellschaft first reported a position in CVS in Q4 2021 and held it in 9 quarters. The position peaked at $11.3M in Q4 2021. 1,948 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

  • Baader Bank Aktiengesellschaft reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 7,077 CVS Health shares in Q4 2025, an estimated $517K.
  • Baader Bank Aktiengesellschaft first reported a position in CVS Health in Q4 2021 and held it in 9 quarters.
  • Baader Bank Aktiengesellschaft's CVS Health position peaked at $11.3M in Q4 2021.
  • 1,948 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q4 2025, filed 5 Feb 2026.